Literature DB >> 7634476

Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists.

W R Hiatt1, A T Hirsch, J G Regensteiner, E P Brass.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7634476     DOI： 10.1161/01.cir.92.3.614

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  38 in total

Review 1.  Beraprost: a review of its pharmacology and therapeutic efficacy in the treatment of peripheral arterial disease and pulmonary arterial hypertension.

Authors:  Ezequiel Balmori Melian; Karen L Goa
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication.

Authors:  Emile R Mohler; John L Gainer; Kim Whitten; Luis H Eraso; Porama Koy Thanaporn; Timothy Bauer
Journal:  Vasc Med       Date:  2011-10       Impact factor: 3.239

3.  Limb Perfusion During Exercise Assessed by Contrast Ultrasound Varies According to Symptom Severity in Patients with Peripheral Artery Disease.

Authors:  Brian P Davidson; James Hodovan; O'Neil R Mason; Federico Moccetti; Avi Gupta; Matthew Muller; J Todd Belcik; Brian H Annex; Jonathan R Lindner
Journal:  J Am Soc Echocardiogr       Date:  2019-06-22       Impact factor: 5.251

4.  Comparing 6-minute walk versus treadmill walking distance as outcomes in randomized trials of peripheral artery disease.

Authors:  Mary M McDermott; Jack M Guralnik; Lu Tian; Lihui Zhao; Tamar S Polonsky; Melina R Kibbe; Michael H Criqui; Dongxue Zhang; Michael S Conte; Kathryn Domanchuk; Lingyu Li; Robert Sufit; Christiaan Leeuwenburgh; Luigi Ferrucci
Journal:  J Vasc Surg       Date:  2019-12-23       Impact factor: 4.268

Review 5.  Combined Lower Limb Revascularisation and Supervised Exercise Training for Patients with Peripheral Arterial Disease: A Systematic Review of Randomised Controlled Trials.

Authors:  Annelise L Menêses; Raphael M Ritti-Dias; Belinda Parmenter; Jonathan Golledge; Christopher D Askew
Journal:  Sports Med       Date:  2017-05       Impact factor: 11.136

6.  Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery disease.

Authors:  Scott Kinlay
Journal:  Circulation       Date:  2013-03-19       Impact factor: 29.690

7.  Fourth Asian PAD Workshop.

Authors: 
Journal:  Ann Vasc Dis       Date:  2013

8.  Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease.

Authors:  Andrew M Wilson; David S Shin; Carlton Weatherby; Randall K Harada; Martin K Ng; Nandini Nair; Jan Kielstein; John P Cooke
Journal:  Vasc Med       Date:  2010-05-19       Impact factor: 3.239

9.  Clinical importance of change in physical activity after endovascular treatment combined with exercise training in patients with peripheral arterial disease.

Authors:  Shota Otsuka; Tomoyuki Morisawa; Satoshi Yuguchi; Yu Hojo; Tomohiro Matsuo; Masaharu Nakajima; Atsuhisa Ishida; Tetsuya Takahashi
Journal:  Heart Vessels       Date:  2016-06-01       Impact factor: 2.037

10.  Diffuse optical characterization of an exercising patient group with peripheral artery disease.

Authors:  Rickson C Mesquita; Mary Putt; Malavika Chandra; Guoqiang Yu; Xiaoman Xing; Sung Wan Han; Gwen Lech; Yu Shang; Turgut Durduran; Chao Zhou; Arjun G Yodh; Emile R Mohler
Journal:  J Biomed Opt       Date:  2013-05       Impact factor: 3.170
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.